| Investor | Toronto Dominion Bank |
13D/G Filings
This page shows a list of all the recent 13D/G filings made by Toronto Dominion Bank . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).
When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.
| Date | Form | Target | Prev Shares |
Current Shares |
Change (Percent) |
Ownership (Percent) |
Change (Percent) |
|
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | 13G/A | GBX / The Greenbrier Companies, Inc. | 1,859,223 | 1,907,755 | ||||
| 2026-05-15 | 13G | IMTX / Immatics N.V. | 7,436,342 | |||||
| 2026-05-15 | 13G/A | PTCT / PTC Therapeutics, Inc. | 4,138,215 | 3,025,945 | ||||
| 2026-05-15 | 13G | URGN / UroGen Pharma Ltd. | 2,302,334 | 2,616,714 | ||||
| 2026-05-15 | 13G/A | STOK / Stoke Therapeutics, Inc. | 3,173,258 | 3,173,258 | ||||
| 2026-02-13 | 13G/A | URGN / UroGen Pharma Ltd. | 3,190,510 | 2,302,334 | ||||
| 2026-02-13 | 13G | PTCT / PTC Therapeutics, Inc. | 4,138,215 | |||||
| 2026-02-13 | 13G | GBX / The Greenbrier Companies, Inc. | 1,859,223 | |||||
| 2025-11-14 | 13G | URGN / UroGen Pharma Ltd. | 3,190,510 | |||||
| 2025-11-14 | 13G | STOK / Stoke Therapeutics, Inc. | 3,173,258 | |||||
| 2025-02-12 | 13D/A | SCHW / The Charles Schwab Corporation | 135,109,332 | 1,329,350 | ||||
| 2024-08-23 | 13D/A | SCHW / The Charles Schwab Corporation | 175,778,751 | 135,109,332 | ||||
| 2023-07-24 | 13D | 350 | ||||||
| 2023-07-19 | 13G | SLAMF / Slam Corp. | 1,598,999 | |||||
| 2022-08-24 | 13G | NPCT / Nuveen Core Plus Impact Fund | ||||||
| 2022-08-03 | 13D/A | SCHW / The Charles Schwab Corporation | 177,604,934 | 175,778,751 | ||||
| 2020-12-31 | 13G | JRO / Nuveen Floating Rate Income Opportunity Fund | ||||||
| 2020-12-31 | 13G | NSL / Nuveen Senior Income Fund | ||||||
| 2020-10-16 | 13D | SCHW / The Charles Schwab Corporation | 177,604,934 | |||||
| 2020-10-07 | 13D/A | / TD AmeriTrade Holding Corp. | 234,513,815 | 0 | ||||
| 2019-11-27 | 13D/A | / TD AmeriTrade Holding Corp. | 234,513,815 | 234,513,815 | ||||
| 2019-11-26 | 13D/A | / TD AmeriTrade Holding Corp. | 234,513,815 | |||||
| 2017-09-25 | 13D/A | / TD AmeriTrade Holding Corp. | 233,993,484 | |||||
| 2017-09-20 | 13D/A | / TD AmeriTrade Holding Corp. | 222,929,287 | 233,993,484 | ||||
| 2016-02-04 | 13D/A | / TD AmeriTrade Holding Corp. | 222,929,287 | |||||
| 2014-02-14 | 13D/A | / TD AmeriTrade Holding Corp. | 222,919,287 | |||||
| 2013-12-09 | 13D/A | / TD AmeriTrade Holding Corp. | 226,919,287 | |||||
| 2013-12-06 | 13D/A | / TD AmeriTrade Holding Corp. | 232,419,287 | |||||
| 2013-05-15 | 13D/A | / TD AmeriTrade Holding Corp. | 232,419,287 | |||||
| 2012-03-16 | 13D/A | / TD AmeriTrade Holding Corp. | 247,419,287 |